Renovaro Biosciences
RENB
#8953
Rank
NZ$0.14 B
Marketcap
$0.89
Share price
3.63%
Change (1 day)
-82.33%
Change (1 year)

EPS for Renovaro Biosciences (RENB)

EPS in 2023 (TTM): -$3.26

According to Renovaro Biosciences's latest financial reports the company's current EPS (TTM) is -$3.45. In 2022 the company made an earnings per share (EPS) of -$3.52 a decrease over its 2021 EPS that were of -$1.35.

EPS history for Renovaro Biosciences from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.26-7.29%
2022-$3.52160.76%
2021-$1.35243.48%
2020-$0.3943.75%
2019-$0.27-74.87%
2018-$1.09339.47%
2017-$0.25-48.26%
2016-$0.48-22.22%
2015-$0.617.39%
2014-$0.574351.27%
2013-$0.0128616.6%
2012-$0.01103